| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/09/1993 | US5192662 Anti-ganglioside GD1 A monoclonal antibody MZ, MZ-producing cells and MZ-containing reagent |
| 03/09/1993 | US5192661 Multicomponent kit containing an antibody to a synthetic antigen of sialic acid |
| 03/09/1993 | US5192538 Stable forms of antigenic Taenia ovis polypeptides |
| 03/09/1993 | US5192537 Method of treating renal cell carcinoma using activated mononuclear cells, renal tumor antigen and cimetidine |
| 03/09/1993 | CA1314246C Anti-ganglioside gd - monoclonal antibody mz, mz-producing cells and mz-containing reagent |
| 03/04/1993 | WO1993004205A1 Monoclonal antibodies to putative hcv e2/ns1 proteins and methods for using same |
| 03/04/1993 | WO1993004187A1 Monoclonal antibody specific for an antigen on dendritic cells |
| 03/04/1993 | WO1993004175A1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |
| 03/04/1993 | WO1993004174A1 Ryegrass pollen allergen |
| 03/04/1993 | WO1993004173A1 Immunoglobulin variants for specific fc epsilon receptors |
| 03/04/1993 | WO1993004163A1 Strain of chlamydia |
| 03/04/1993 | WO1993004089A1 Hepatitis c assay utilizing recombinant antigens from ns5 region |
| 03/04/1993 | WO1993004087A1 Hepatitis c assay utilizing recombinant antigens to c-100 region |
| 03/04/1993 | WO1993004086A1 Receptors for advanced glycosylation endproducts and uses thereof |
| 03/04/1993 | WO1993004085A1 Anti-hiv proteins gap 31, dap 30 and dap 32, dna coding therefor and therapeutic uses thereof |
| 03/04/1993 | WO1993004084A1 Monoclonal antibodies to putative hcv ns5 proteins and methos for using same |
| 03/04/1993 | WO1993003761A1 METHODS AND COMPOSITIONS RELATING TO USEFUL ANTIGENS OF $i(MORAXELLA CATARRHALIS) |
| 03/04/1993 | WO1993003760A1 Sirs vaccine and diagnosis method |
| 03/04/1993 | WO1993003759A1 Papua new guinea human t-lymphotropic virus |
| 03/04/1993 | WO1992020796A3 D-type cyclin and uses related thereto |
| 03/04/1993 | CA2145382A1 Methods and compositions for cancer therapy and for prognosticating responses to cancer therapy |
| 03/04/1993 | CA2116359A1 Anti-hiv proteins gap 31, dap 30, and dap 32, dna coding therefor and therapeutic uses thereof |
| 03/04/1993 | CA2115925A1 Hepatitis c assay utilizing recombinant antigens from ns5 region |
| 03/04/1993 | CA2115923A1 Monoclonal antibodies to putative hcv e2/ns1 proteins and methods for using same |
| 03/04/1993 | CA2115554A1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |
| 03/03/1993 | EP0529995A1 Human KA-2 receptor, a kainate high affinity receptor of the EAA2 (Excitatory Amino Acid) family |
| 03/03/1993 | EP0529994A1 Human KA-1 receptor, a kainate high affinity receptor of the EAA1 (Excitatory Amino Acid) family |
| 03/03/1993 | EP0529742A1 Alpha-amidating enzyme compositions and processes for their production and use |
| 03/03/1993 | EP0529719A1 Assay for evaluating inhibition of PMN elastase by N-Substituted Azetidinones |
| 03/03/1993 | EP0529622A2 Cloning and characterization of a cardiac adenylyl cyclase |
| 03/03/1993 | EP0529584A2 Viral agent associated with the Mystery Swine Disease |
| 03/03/1993 | EP0529348A1 Process for the purification of factor XIII, monoclonal antibodies against factor XIIIA, preparation and use thereof |
| 03/03/1993 | EP0529065A1 Receptor-based screening methods for amylin agonists and antagonists |
| 03/03/1993 | EP0529033A1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof |
| 03/03/1993 | EP0529030A1 Composition of antibodies directed against the humain or animal interleukin-2 receiver |
| 03/03/1993 | EP0529007A1 A 35kD TUMOR ASSOCIATED PROTEIN ANTIGEN: USES AND METHODS OF DETECTION |
| 03/03/1993 | EP0528951A1 Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof |
| 03/03/1993 | EP0528931A1 Humanized chimeric anti-icam-1 antibodies, methods of preparation and use |
| 03/03/1993 | EP0528926A1 Soluble peptide analogues containing binding sites |
| 03/03/1993 | EP0528881A1 Methods for phenotype creation from multiple gene populations |
| 03/03/1993 | EP0528870A1 Protein-nucleic acid probes and immunoassays using same |
| 03/03/1993 | EP0517805A4 Identification and expression of insect steroid receptor dna sequences |
| 03/03/1993 | CN1069522A Intercellular adhesion molecule-3 and its binding ligands |
| 03/02/1993 | USH1148 Method of separating activated human protein C |
| 03/02/1993 | US5191068 Removal of cells from an aqueous suspension |
| 03/02/1993 | US5191066 Site-specific conjugation of immunoglobulins and detectable labels |
| 03/02/1993 | US5191015 Polymers and polymer-peptide conjugates |
| 03/02/1993 | US5190920 Method for using synthetic analogs of thrombospondin for inhibiting metastasis activity |
| 03/02/1993 | US5190919 Antihemostatic factor vii peptides |
| 03/02/1993 | US5190918 Peptide fragments and analogs of thrombospondin and methods of use |
| 03/02/1993 | US5190865 Antibody-enhanced stereospecific hydrolyses |
| 03/02/1993 | US5190861 Method for the diagnosis of rheumatoid arthritis |
| 03/02/1993 | US5190860 Differential diagnostic assay for brucellosis |
| 03/02/1993 | US5190859 Purification of LFA-3 |
| 03/02/1993 | US5190858 Bonding tissues |
| 03/02/1993 | US5190752 Intravenously administerable polyclonal immunoglobulin preparation containing igm and method of manufacture |
| 03/01/1993 | WO1993005152A1 Antibodies to streptolysin o derivatives and variants |
| 03/01/1993 | CA2094242A1 Antibodies to streptolysin o derivatives and variants |
| 03/01/1993 | CA2076995A1 Cloning and characterization of a cardiac adenylyl cyclase |
| 02/27/1993 | CA2076798A1 Kainate-binding, human cns receptors of the eaa1 family |
| 02/27/1993 | CA2076403A1 Assay for evaluating inhibition of pmn elastase by n-substituted azetidinones |
| 02/24/1993 | EP0528767A1 Antibody derivatives |
| 02/24/1993 | EP0528663A2 Monoclonal antibody to a synaptophysin |
| 02/24/1993 | EP0528527A2 Conjugates |
| 02/24/1993 | EP0528525A1 Assay methods and compositions for detecting serum proteases,particularly activated protein C. |
| 02/24/1993 | EP0528469A1 Recombinant DNA-molecule for the expression of the FV-fragment of an antibody |
| 02/24/1993 | EP0528011A1 CD4-GAMMA2 AND CD4-IgG2 CHIMERAS |
| 02/24/1993 | EP0528007A1 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF $g(b) CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 02/24/1993 | EP0527971A1 Composition and method for immunostimulation in mammals |
| 02/24/1993 | EP0527954A1 Molecular recognition units |
| 02/24/1993 | EP0527839A1 Recombinant library screening methods |
| 02/24/1993 | EP0527804A1 Gene therapy for cell proliferative diseases |
| 02/24/1993 | EP0527789A1 Hiv envelope polypeptides |
| 02/24/1993 | EP0527786A1 Purified hcv and hcv proteins and peptides |
| 02/24/1993 | EP0527785A1 Improvements relating to the detection of viruses |
| 02/24/1993 | EP0527755A1 Improved method for radiolabeling monovalent antibody fragments |
| 02/23/1993 | WO1993004090A1 Hiv immunotherapeutics |
| 02/23/1993 | WO1993003741A1 Methods and compositions for cancer therapy and for prognosticating responses to cancer therapy |
| 02/23/1993 | US5188969 Monoclonal antibody to human lymphotoxin and use thereof |
| 02/23/1993 | US5188967 Contacting sample tissue or serum from human with a reagent recognizing gene coding for human villin |
| 02/23/1993 | US5188942 Method for determining bluetongue virus antibodies in serum |
| 02/23/1993 | CA1313828C Monoclonal antibodies to superficial papillary bladder tumor cells |
| 02/23/1993 | CA1313820C High titer anti-respiratory syncytial virus intravenous immune globulin |
| 02/18/1993 | WO1993003381A1 Assay for free secretory component and methods for monitoring organ rejection |
| 02/18/1993 | WO1993003375A1 Autoantibodies and their targets in the diagnosis of peripheral neuropathies |
| 02/18/1993 | WO1993003371A1 Reagents and methods for the quantification of imipramine or desipramine in biological fluids |
| 02/18/1993 | WO1993003370A1 Reagents and methods for the quantification of amitriptyline or nortriptyline in biological fluids |
| 02/18/1993 | WO1993003369A1 Diagnostic method for alzheimer's disease |
| 02/18/1993 | WO1993003344A2 Haptens, tracers, immunogens and antibodies for immunoassays for propoxyphene |
| 02/18/1993 | WO1993003151A1 Treatment of cell populations |
| 02/18/1993 | WO1993003148A2 Tau/neurofilament protein kinases pk40 and pk36 |
| 02/18/1993 | WO1993003146A1 Disease associated b-cell epitopes of tpo and use thereof |
| 02/18/1993 | WO1993003057A1 Polypeptides capable of in vivo induction of antibodies themselves capable of inhibiting the invasion of red blood corpuscles by merozoites of p.falciparum, related products and their use in producing vaccine compositions |
| 02/18/1993 | WO1993003050A1 Novel cyclophilins, associating proteins and uses |
| 02/18/1993 | WO1993002704A1 Mixture of peptide constituents having vaccinating properties against paludism particularly due to plasmodium falciparum |
| 02/18/1993 | WO1993002703A1 Prodrugs activated by targeted catalytic proteins |
| 02/18/1993 | WO1993002702A1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
| 02/18/1993 | WO1993002698A1 Monoclonal antibodies to leukocyte adhesion molecule-1 |
| 02/18/1993 | WO1993002693A2 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 02/18/1993 | WO1993002691A1 Steroid hormone drug delivery |